BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16679287)

  • 1. FSH versus estrogen: who's guilty of breaking bones?
    Baron R
    Cell Metab; 2006 May; 3(5):302-5. PubMed ID: 16679287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSH and bone--important physiology or not?
    Prior JC
    Trends Mol Med; 2007 Jan; 13(1):1-3. PubMed ID: 17141571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSH directly regulates bone mass.
    Sun L; Peng Y; Sharrow AC; Iqbal J; Zhang Z; Papachristou DJ; Zaidi S; Zhu LL; Yaroslavskiy BB; Zhou H; Zallone A; Sairam MR; Kumar TR; Bo W; Braun J; Cardoso-Landa L; Schaffler MB; Moonga BS; Blair HC; Zaidi M
    Cell; 2006 Apr; 125(2):247-60. PubMed ID: 16630814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and bone: osteoclasts take center stage.
    Novack DV
    Cell Metab; 2007 Oct; 6(4):254-6. PubMed ID: 17908554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone loss goes beyond estrogen.
    Martin TJ; Gaddy D
    Nat Med; 2006 Jun; 12(6):612-3. PubMed ID: 16761003
    [No Abstract]   [Full Text] [Related]  

  • 6. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.
    Zaidi M; Blair HC; Iqbal J; Davies TF; Zhu LL; Zallone A; Sun L
    Curr Rheumatol Rep; 2009 Jul; 11(3):191-5. PubMed ID: 19604463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone metabolism by sex hormones and gonadotropins].
    Imai Y
    Clin Calcium; 2014 Jun; 24(6):815-9. PubMed ID: 24870831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal receptors for steroid-family regulating glycoprotein hormones: A multilevel, integrated physiological control system.
    Blair HC; Robinson LJ; Sun L; Isales C; Davies TF; Zaidi M
    Ann N Y Acad Sci; 2011 Dec; 1240():26-31. PubMed ID: 22172036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormones and osteoporosis update. Possible roles of pituitary hormones, TSH and FSH, for bone metabolism].
    Takeuchi Y
    Clin Calcium; 2009 Jul; 19(7):977-83. PubMed ID: 19567994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis.
    Zaidi M; Iqbal J; Blair HC; Zallone A; Davies T; Sun L
    Mt Sinai J Med; 2009 Oct; 76(5):474-83. PubMed ID: 19787657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
    Zhu D; Li X; Macrae VE; Simoncini T; Fu X
    Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FSH aggravates periodontitis-related bone loss in ovariectomized rats.
    Liu S; Cheng Y; Fan M; Chen D; Bian Z
    J Dent Res; 2010 Apr; 89(4):366-71. PubMed ID: 20139335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary-FSH and bone 2010: evolving evidence.
    Iqbal J; Sun L; Zaidi M
    Eur J Endocrinol; 2010 Jul; 163(1):173-6. PubMed ID: 20448000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for direct pro-resorptive actions of FSH.
    Sun L; Zhang Z; Zhu LL; Peng Y; Liu X; Li J; Agrawal M; Robinson LJ; Iqbal J; Blair HC; Zaidi M
    Biochem Biophys Res Commun; 2010 Mar; 394(1):6-11. PubMed ID: 20171951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro.
    Ritter V; Thuering B; Saint Mezard P; Luong-Nguyen NH; Seltenmeyer Y; Junker U; Fournier B; Susa M; Morvan F
    Calcif Tissue Int; 2008 May; 82(5):383-91. PubMed ID: 18465073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteoporosis and oral biology].
    Ikeo T; Kamada A; Goda S
    Clin Calcium; 2007 Feb; 17(2):150-6. PubMed ID: 17272870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadal bone loss: sex steroids or gonadotropins?
    Williams GR
    Endocrinology; 2007 Jun; 148(6):2610-2. PubMed ID: 17507579
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts.
    Seitz S; Keller J; Schilling AF; Jeschke A; Marshall RP; Stride BD; Wintermantel T; Beil FT; Amling M; Schütz G; Tuckermann J; Schinke T
    PLoS One; 2012; 7(11):e50301. PubMed ID: 23209701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?
    Chin KY
    Int J Med Sci; 2018; 15(12):1373-1383. PubMed ID: 30275766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroids, not FSH, influence bone mass.
    Seibel MJ; Dunstan CR; Zhou H; Allan CM; Handelsman DJ
    Cell; 2006 Dec; 127(6):1079; author reply 1080-1. PubMed ID: 17174881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.